| [1] |
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med, 2011, 364(23): 2187-2198.
doi: 10.1056/NEJMoa1103510
URL
|
| [2] |
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. New Engl J Med, 2016, 374(17): 1609-1620.
doi: 10.1056/NEJMoa1514616
URL
|
| [3] |
Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients[J]. New Engl J Med, 2017, 376(14): 1321-1331.
doi: 10.1056/NEJMoa1700456
URL
|
| [4] |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J]. N Engl J Med, 2019, 380(18): 1695-1705.
doi: 10.1056/NEJMoa1814052
URL
|
| [5] |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med, 2019, 380(18): 1706-1715.
doi: 10.1056/NEJMoa1816885
URL
|
| [6] |
Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry[J]. J Am Coll Cardiol, 2015, 65(20): 2173-2180.
doi: 10.1016/j.jacc.2015.03.034
pmid: 25787198
|
| [7] |
D’Ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results[J]. EuroIntervention, 2018, 14(11): e1169-e1177.
doi: 10.4244/EIJ-D-18-00098
URL
|
| [8] |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease[J]. Circulation, 2021, 143(5): e72-e227.
|
| [9] |
van den Boogert TPW, Vendrik J, Claessen BEPM, et al. CTCA for detection of significant coronary artery disease in routine TAVI work-up[J]. Neth Heart J, 2018, 26(12): 591-599.
doi: 10.1007/s12471-018-1149-6
pmid: 30178209
|
| [10] |
Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2019, 74(3): 362-372.
doi: 10.1016/j.jacc.2019.06.012
URL
|
| [11] |
Tarus A, Tinica G, Bacusca A, et al. Coronary revascularization during treatment of severe aortic stenosis[J]. J Cardiac Surg, 2020, 35(8): 2009-2016.
doi: 10.1111/jocs.14814
URL
|
| [12] |
Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI[J]. Clin Res Cardiol, 2015, 104(8): 632-639.
doi: 10.1007/s00392-015-0824-5
pmid: 25720330
|
| [13] |
van Rosendael PJ, van der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter aortic valve implantation[J]. Am J Cardiol, 2015, 115(12): 1726-1732.
doi: 10.1016/j.amjcard.2015.03.019
pmid: 25890631
|
| [14] |
Singh V, Rodriguez AP, Thakkar B, et al. Comparison of outcomes of transcatheter aortic valve replacement plus percutaneous coronary intervention versus transcatheter aortic valve replacement alone in the United States[J]. Am J Cardiol, 2016, 118(11): 1698-1704.
doi: 10.1016/j.amjcard.2016.08.048
URL
|
| [15] |
Penkalla A, Pasic M, Drews T, et al. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach[J]. Eur J Cardiothorac Surg, 2015, 47(6): 1083-1089.
doi: 10.1093/ejcts/ezu339
pmid: 25217500
|
| [16] |
Barbanti M, Todaro D, Costa G, et al. Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc percutaneous coronary intervention during transcatheter aortic valve replacement[J]. Circ Cardiovasc Interv, 2017, 10(8): e005234.
doi: 10.1161/CIRCINTERVENTIONS.117.005234
URL
|
| [17] |
Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry[J]. J Am Coll Cardiol, 2013, 62(17): 1552-1562.
doi: 10.1016/j.jacc.2013.07.040
URL
|
| [18] |
Rodés-Cabau J, Ribeiro HB. Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction[J]. EuroIntervention, 2020, 16(8): 617-619.
doi: 10.4244/EIJV16I8A114
pmid: 33095163
|
| [19] |
Vilalta V, Asmarats L, Ferreira-Neto AN, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2018, 11(24): 2523-2533.
doi: 10.1016/j.jcin.2018.09.001
URL
|
| [20] |
Mentias A, Desai MY, Saad M, et al. Incidence and outcomes of acute coronary syndrome after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2020, 13(8): 938-950.
doi: 10.1016/j.jcin.2019.11.027
URL
|
| [21] |
Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap[J]. JACC Cardiovasc Interv, 2020, 13(9): 1030-1042.
doi: 10.1016/j.jcin.2020.02.005
URL
|
